Ieq Capital LLC Purchases New Holdings in The Cooper Companies, Inc. $COO

Ieq Capital LLC purchased a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 163,614 shares of the medical device company’s stock, valued at approximately $11,733,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. BlackRock Inc. bought a new stake in shares of Cooper Companies during the 2nd quarter valued at $1,077,762,000. Generation Investment Management LLP bought a new position in shares of Cooper Companies in the second quarter worth $356,304,000. Wellington Management Group LLP raised its stake in Cooper Companies by 332.9% in the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after purchasing an additional 4,756,178 shares in the last quarter. Diamond Hill Capital Management Inc. lifted its position in Cooper Companies by 479.6% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock worth $269,471,000 after purchasing an additional 2,720,594 shares during the period. Finally, Price T Rowe Associates Inc. MD lifted its position in Cooper Companies by 58.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after purchasing an additional 2,231,568 shares during the period. 24.39% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have weighed in on COO. Citigroup restated a “neutral” rating and set a $80.00 target price (up from $76.00) on shares of Cooper Companies in a research note on Thursday, August 13th. Robert W. Baird lowered their price target on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a report on Friday, June 5th. KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. Needham & Company LLC reduced their price objective on Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a research note on Friday, June 5th. Finally, UBS Group started coverage on Cooper Companies in a research report on Tuesday, July 28th. They issued a “neutral” rating and a $75.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $81.64.

Cooper Companies Stock Performance

Shares of Cooper Companies stock opened at $76.22 on Friday. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The firm has a market capitalization of $14.87 billion, a P/E ratio of 64.59, a P/E/G ratio of 1.99 and a beta of 0.83. The company’s 50 day moving average price is $71.93 and its two-hundred day moving average price is $71.16.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same period in the prior year, the business earned $0.96 earnings per share. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.